CO6251362A2 - Derivados de n-heteroaril-carboxamidas triciclicas su preparacion y su aplicacion en la terapeutica - Google Patents
Derivados de n-heteroaril-carboxamidas triciclicas su preparacion y su aplicacion en la terapeuticaInfo
- Publication number
- CO6251362A2 CO6251362A2 CO10010102A CO10010102A CO6251362A2 CO 6251362 A2 CO6251362 A2 CO 6251362A2 CO 10010102 A CO10010102 A CO 10010102A CO 10010102 A CO10010102 A CO 10010102A CO 6251362 A2 CO6251362 A2 CO 6251362A2
- Authority
- CO
- Colombia
- Prior art keywords
- atom
- pyrrolo
- pyridinyl
- group
- therapeutics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invención se refiere a os derivados de N-heteroaril-carboxamidas tricíclicas, de fórmula general (I) en la que A representa, con el enlace Z2-Z3 del biciclo al que está unido, un grupo cicloalquilo C4-C7, un heteroarilo monocíclico o un heterociclo monocíclico de 4 a 7 eslabones que comprende de uno a tres heteroátomos elegidos entre O, S o N, incluidos los átomos Z2 y Z3 Z1, Z5, Z6, Z7 y Z8 representan, independientemente uno de otro, un átomo de nitrógeno, un átomo de carbono o un grupo C-R2; Z2, Z3, Z4 y Z9 representan, independientemente uno de otro, un átomo de nitrógeno o un átomo de carbono y Z1, Z2, Z3, Z4, Z5, Z6, Z7, Z8 y Z9 forman juntos un heteroarilo bicíclico unido al átomo de nitrógeno de la amida o la tioamida de fórmula (I) por las posiciones Z5, Z6, Z7 o Z8 cuando estas posiciones corresponden a un átomo de carbono, correspondiendo uno al menos de Z4, Z5, Z6, Z7, Z8 y Z9 a un átomo de nitrógeno; W representa un átomo de oxígeno o de azufre; P representa un grupo indolilo, pirrolo[2.3-c]piridinilo, pirrolo[2.3b]piridinilo, pirrolo[3.2-b]piridinilo o pirrolo[3.2-c]piridinilo, estando este grupo sustituido. Procedimiento de preparación y aplicación en terapéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705677A FR2919610B1 (fr) | 2007-08-02 | 2007-08-02 | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6251362A2 true CO6251362A2 (es) | 2011-02-21 |
Family
ID=39185736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10010102A CO6251362A2 (es) | 2007-08-02 | 2010-02-01 | Derivados de n-heteroaril-carboxamidas triciclicas su preparacion y su aplicacion en la terapeutica |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8153796B2 (es) |
| EP (1) | EP2185558B1 (es) |
| JP (1) | JP5259713B2 (es) |
| KR (1) | KR20100041804A (es) |
| CN (1) | CN101772499B (es) |
| AR (1) | AR067754A1 (es) |
| AU (1) | AU2008313601B2 (es) |
| BR (1) | BRPI0814756A2 (es) |
| CA (1) | CA2694994C (es) |
| CL (1) | CL2008002289A1 (es) |
| CO (1) | CO6251362A2 (es) |
| EA (1) | EA017808B1 (es) |
| FR (1) | FR2919610B1 (es) |
| MA (1) | MA31687B1 (es) |
| MX (1) | MX2010001238A (es) |
| MY (1) | MY150428A (es) |
| NZ (1) | NZ582970A (es) |
| PA (1) | PA8790901A1 (es) |
| PE (1) | PE20090565A1 (es) |
| SG (1) | SG183080A1 (es) |
| TW (1) | TWI366566B (es) |
| UY (1) | UY31264A1 (es) |
| WO (1) | WO2009050348A1 (es) |
| ZA (1) | ZA201000745B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA032315B1 (ru) * | 2015-03-18 | 2019-05-31 | Бристол-Маерс Сквибб Компани | Замещенные трициклические гетероциклические соединения |
| EP3320241A4 (en) | 2015-07-09 | 2018-07-18 | Vistadeltek, LLC | Control plate in a valve |
| DK3340796T3 (da) | 2015-08-28 | 2021-07-26 | Chdi Foundation Inc | Sonder til afbildning af huntingtin-protein |
| WO2022111473A1 (en) * | 2020-11-26 | 2022-06-02 | Bioardis Llc | Compounds as mrgprx2 antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0156327B1 (ko) * | 1995-07-12 | 1998-11-16 | 김종인 | 벤즈 또는 피리도이미다졸 유도체 |
| US6313242B1 (en) * | 1996-05-20 | 2001-11-06 | Fina Technology, Inc. | Stereorigid bis-fluorenyl metallocenes |
| US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
| DE602004024375D1 (de) * | 2003-02-14 | 2010-01-14 | Glaxo Group Ltd | Carboxamidderivate |
| US20050004133A1 (en) * | 2003-06-05 | 2005-01-06 | Makings Lewis R. | Modulators of VR1 receptor |
| GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
| FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2897061B1 (fr) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. |
-
2007
- 2007-08-02 FR FR0705677A patent/FR2919610B1/fr active Active
-
2008
- 2008-07-29 PA PA20088790901A patent/PA8790901A1/es unknown
- 2008-07-30 TW TW097128801A patent/TWI366566B/zh not_active IP Right Cessation
- 2008-07-31 KR KR1020107002302A patent/KR20100041804A/ko not_active Application Discontinuation
- 2008-07-31 CN CN2008801014470A patent/CN101772499B/zh not_active Expired - Fee Related
- 2008-07-31 BR BRPI0814756A patent/BRPI0814756A2/pt not_active IP Right Cessation
- 2008-07-31 CA CA2694994A patent/CA2694994C/fr not_active Expired - Fee Related
- 2008-07-31 EA EA201070217A patent/EA017808B1/ru not_active IP Right Cessation
- 2008-07-31 SG SG2012055265A patent/SG183080A1/en unknown
- 2008-07-31 MX MX2010001238A patent/MX2010001238A/es active IP Right Grant
- 2008-07-31 NZ NZ582970A patent/NZ582970A/en not_active IP Right Cessation
- 2008-07-31 EP EP08839139.6A patent/EP2185558B1/fr active Active
- 2008-07-31 AU AU2008313601A patent/AU2008313601B2/en not_active Ceased
- 2008-07-31 WO PCT/FR2008/001141 patent/WO2009050348A1/fr active Application Filing
- 2008-07-31 AR ARP080103318A patent/AR067754A1/es not_active Application Discontinuation
- 2008-07-31 JP JP2010518710A patent/JP5259713B2/ja not_active Expired - Fee Related
- 2008-07-31 MY MYPI20100448 patent/MY150428A/en unknown
- 2008-07-31 PE PE2008001286A patent/PE20090565A1/es not_active Application Discontinuation
- 2008-08-01 UY UY31264A patent/UY31264A1/es not_active Application Discontinuation
- 2008-08-01 CL CL2008002289A patent/CL2008002289A1/es unknown
-
2010
- 2010-01-29 US US12/696,149 patent/US8153796B2/en not_active Expired - Fee Related
- 2010-02-01 ZA ZA2010/00745A patent/ZA201000745B/en unknown
- 2010-02-01 CO CO10010102A patent/CO6251362A2/es active IP Right Grant
- 2010-03-01 MA MA32663A patent/MA31687B1/fr unknown
-
2012
- 2012-03-06 US US13/412,855 patent/US8420817B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2010000227A (es) | Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion terapeutica | |
| DOP2010000215A (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica | |
| PE20050951A1 (es) | Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas | |
| ECSP088105A (es) | Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica | |
| CO6251362A2 (es) | Derivados de n-heteroaril-carboxamidas triciclicas su preparacion y su aplicacion en la terapeutica | |
| NI201000124A (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
| AR064877A1 (es) | Derivados de glicina n-sustituidos: inhibidores de prolil hidroxilasa | |
| ECSP088253A (es) | Derivados de azol y tiazol y sus usos | |
| PA8786101A1 (es) | "DERIVADOS DE 6-CICLOAMINO-3-(PIRIDIN-4-IL) IMIDAZO[1,2-b]-PIRIDAZINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA" | |
| PE20080114A1 (es) | Derivados de heteroarilo biciclicos como moduladores del receptor canabinoide | |
| PE20071090A1 (es) | 5-pirazolpiperidinas-(sustituidas) | |
| ECSP056016A (es) | Nuevos derivados de 2-piridinacarboxamida | |
| CO5700780A2 (es) | Derivados de quinolina como inhibidores, selectivos, de de fosfodiesterasa pde 4b | |
| PE20050576A1 (es) | Compuestos de pirazolilo e imidazolilo biciclicos como ligandos de receptores cannabinoides | |
| CY1112006T1 (el) | Μακροκυκλικοι αναστολεις του ιου της ηπατιτιδας c | |
| WO2007048847A3 (en) | Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases | |
| NO20080871L (no) | N-(Heteroaryl)-1-heteroarylalkyl-1 H-indol-2-karboksamidderivater, fremstilling og terapeutisk anvendelse derav | |
| CO6150181A2 (es) | Compuesto 6-(bencilo sustituido con heterociclo)-4-oxoquinolina y su uso como inhibidor de integrasa vih | |
| PE20091811A1 (es) | DERIVADOS DE IMIDAZOLIDINONA COMO INHIBIDORES DE 11b-HSD1 | |
| ECSP10010380A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| PE20231097A1 (es) | Compuestos heterociclicos como inhibidores de delta-5 desaturasa y metodos de uso | |
| AR056418A1 (es) | Derivados de bencimidazol como 5-ht6, 5-ht2a, metodo para la obtencion del compuesto y el uso para la fabricacion de un mediicamento | |
| AR053341A1 (es) | Derivados azol triciclicos su fabricacion y uso como agentes farmaceuticos | |
| MXPA05011276A (es) | Derivado heterociclico de cinco miembros. | |
| ATE532791T1 (de) | In der 8-stellung modifiziertes purin- nukleosidderivat und dessen medizinische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |